Wednesday 04/February/2026 – 10:19 AM
Company revealed Memphis Pharmaceuticals and Chemical Industries, about the reality of its expansion plans and developments in the disposition of some of its real estate assets, according to a disclosure today, Wednesday, to the Egyptian Stock Exchange.
The company explained that it is studying the technical and financial offers submitted to sell a plot of land it owns with an area of 2,426.95 square meters, in addition to studying offers to purchase new machines and production lines for ampoules and ointments at an investment cost of 288 million pounds.
The company stressed that these moves are still in the planning and studies stage only, stressing its full commitment to the provisions of Articles 43 bis and 44 of the rules for listing and delisting securities on the Egyptian Stock Exchange, and disclosing any developments as soon as they occur.
Memphis Pharmaceuticals’ earnings for the first quarter of 2025/2026
The business results of the Memphis Pharmaceutical and Chemical Industries Company for the 6 months ending on December 31, 2025 achieved a profit growth of 5%, recording profits worth 281.7 million pounds, compared to profits worth 268 million pounds during the first half of 2024/2025.
Revenues amounted to 955.5 million pounds for the first half of 2025/2026, compared to revenues of 787.9 million pounds for the first 6 months of 2024/2025, an increase of 21%.
The business results of the Memphis Pharmaceutical and Chemical Industries Company for the 3 months ending on September 30, 2025, achieved an increase in profits, recording 152.9 million pounds, compared to profits amounting to 140.8 million pounds for the first quarter of 2024/2025.
Activity revenues amounted to 497.8 million pounds for the first quarter of 2025/2026, compared to activity revenues of 399.6 million pounds for the first 3 months of 2024/2025.
